The longevity transporter mIndy (Slc13a5) as a target for treating hepatic steatosis and insulin resistance

Aging (Albany NY). 2016 Feb;8(2):208-9. doi: 10.18632/aging.100907.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Fatty Liver / metabolism*
  • Humans
  • Insulin Resistance / physiology*
  • Longevity / physiology
  • Symporters / metabolism*

Substances

  • SLC13A5 protein, human
  • Symporters